Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
January 1, 1995
Sarcoidosis in a uterine leiomyoma
A W Menzin, T T You, R B Deger, et al.
Obstetrical & Gynecological Survey
|
May 11, 1999
Primary peritoneal carcinoma: a review of the literature
C S Chu, A W Menzin, D G Leonard, et al.
Gynecologic Oncology
|
July 1, 1994
Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer
A W Menzin, S A King, J K Aikins, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 1995
Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site
R F Feinberg, H J Kliman, V Bedian, et al.
Cancer
|
January 15, 1998
Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants
A W Menzin, J R Loret de Mola, W B Bilker, et al.
Molecular Carcinogenesis
|
December 30, 1998
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q
O van der Heijden, H C Chiu, T C Park, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
January 1, 1995
Sarcoidosis in a uterine leiomyoma
A W Menzin, T T You, R B Deger, et al.
Obstetrical & Gynecological Survey
|
May 11, 1999
Primary peritoneal carcinoma: a review of the literature
C S Chu, A W Menzin, D G Leonard, et al.
Gynecologic Oncology
|
July 1, 1994
Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer
A W Menzin, S A King, J K Aikins, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 1995
Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site
R F Feinberg, H J Kliman, V Bedian, et al.
Cancer
|
January 15, 1998
Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants
A W Menzin, J R Loret de Mola, W B Bilker, et al.
Molecular Carcinogenesis
|
December 30, 1998
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q
O van der Heijden, H C Chiu, T C Park, et al.
Page
of 2